Schröder H C, Ushijima H, Theis C, Sève A P, Hubert J, Müller W E
Institut für Physiologische Chemie, Abteilung für Angewandte Molekularbiologie, Mainz, Germany.
J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Aug 1;9(4):340-8.
The nuclear carbohydrate-binding protein 35 (CBP35), a beta-galactoside-specific lectin with an M(r) of 35,000, has been identified in nuclear ribonucleoprotein complexes (RNPs) from a variety of mammalian tissues and cells. Here we determined that the expression of CBP35 mRNA greatly increases after infection of Molt-3 cells with human immunodeficiency virus type 1 (HIV-1), concomitantly with the onset of expression of the viral regulatory gene tat, and then declines. The increase in CBP35 mRNA level results in an enhanced synthesis of CBP35, as evidenced in nitrocellulose filter binding assay using radiolabeled, sugar-specific neoglycoprotein. Immunoblotting experiments showed that CBP35 is present in the 40S heterogeneous nuclear RNP complex from HIV-1-infected Molt-3 cells. CBP35 could also be detected using a novel photoreactive alpha-D-galactose probe designed for the specific detection of CBP.
核碳水化合物结合蛋白35(CBP35)是一种分子量为35,000的β-半乳糖苷特异性凝集素,已在来自多种哺乳动物组织和细胞的核糖核蛋白复合物(RNP)中被鉴定出来。在此,我们确定,在人免疫缺陷病毒1型(HIV-1)感染Molt-3细胞后,CBP35 mRNA的表达大幅增加,这与病毒调节基因tat表达的开始同时发生,随后下降。CBP35 mRNA水平的增加导致CBP35的合成增强,这在使用放射性标记的、糖特异性新糖蛋白的硝酸纤维素滤膜结合试验中得到了证实。免疫印迹实验表明,CBP35存在于来自HIV-1感染的Molt-3细胞的40S异质性核RNP复合物中。使用一种专为特异性检测CBP设计的新型光反应性α-D-半乳糖探针,也能检测到CBP35。